About
NeuroXess (Shanghai Naohu Technology Co., Ltd.), founded in Shanghai in October 2021, develops implantable flexible brain-computer interface systems built on silk-protein flexible electrodes, high-throughput neural acquisition chips, neural decoding algorithms and surgical robots, offering motion decoding, speech decoding and environment control for patients with epilepsy, glioma, ALS, paraplegia and post-stroke conditions, plus a brain-science research offering.
Full tier & rationale — an SVTR Intelligence benefit
Capital graph
Investor· 10
Funding history
- 2026-10-28Series B$97M
Investors · 国投聚力, Shenzhen Capital Group, 勤智资本, China Fortune-Tech Capital, 黄浦投资, CoStone Capital, IDG Capital, 曦晨资本, 钧犀资本, 华福证券, 华赛智汇, 众为资本, 江西金控, 盛大, 中平资本Source · chinaventure.com.cn ↗
Comparable companies· by market
This company
BusinessLatest roundTotal raisedDate- NeuroXess
Implantable flexible brain-computer interface systems (neural signal acquisition chips + decoding algorithms) for patients with neurological disorders
Series B · 2026-10
—
United States
BusinessLatest roundTotal raisedDate- Coherence Neuro
Closed-loop brain-computer interface system SOMA, using a wireless implant to decode tumor electrical signals in real time and deliver personalized electrical stimulation to treat brain tumors and other cancers
Series A · 2026-10
— - Blackrock Neurotech
Develops brain-computer interface technology designed to help patients with paralysis or other neurological conditions control digital devices and regain mobility
Undisclosed · $200M · 2024-05
$200M - Axoft
Implantable brain-computer interfaces using biomimetic materials, with flexible neural electronics for high-resolution neural recording and stimulation
Series A · $60M · 2026-05
$60M
China
BusinessLatest roundTotal raisedDate- SiClink
Implantable brain-computer interfaces: in-house flexible neural electrodes and minimally invasive implantation with neural decoding/encoding algorithms, starting with visual restoration for visual impairment rehabilitation
— - BCI-Sonics
Non-invasive AI ultrasound brain-computer interface (transcranial focused ultrasound neuromodulation + multimodal brain reading and AI neural decoding)
Series A · $42M · 2026-09
$42M - Medlink
Brain-computer interface rehabilitation devices: L-B300 EEG acquisition and rehabilitation training device that detects motor imagery intent to drive upper and lower limb training
Series B · 2026-10
—
Europe
BusinessLatest roundTotal raisedDate- MintNeuro
Imperial College London spinout developing composable chip modules for neural signal acquisition, electrical stimulation, on-chip processing and wireless transmission, for BCI and active implant makers
Undisclosed · 2026-10
— - InBrain Neuroelectronics
Graphene-based brain-computer interface technology for neurological disorders such as Parkinson's disease.
Series B · $50M · 2024-11
$50M - Neurosoft Bioelectronics
Flexible, stretchable, non-penetrating brain-computer interfaces and neural electrodes to record/stimulate brain-surface activity
Seed · $20M · 2026-05
$20M
Other / unspecified
BusinessLatest roundTotal raisedDate- 脑思科技
Brain-computer interface electrodes and neural decoding systems
Angel · $10M · 2026-05
$10M - Brain.space
Non-invasive brain monitoring platform with real-time neural data analysis
Series A · $11M · 2025-03
$11M - CustoMED
AI and 3D printing to produce patient-specific orthopedic surgical tools and implants
Seed · $6M · 2025-11
$6M
Confirmed rounds only. Matched on subsector, sector, stage and funding scale — each verifiable on the company profiles.
Investors that may fit
Dimension Capital
10 Life Sciences deals in the last 24 months · 5 at a nearby stage · 1 in East China
Request intro →OrbiMed Advisors
9 Life Sciences deals in the last 24 months · 5 at a nearby stage · 4 in East China
Request intro →Qiming Venture Partners
9 Life Sciences deals in the last 24 months · 6 at a nearby stage · 7 in East China
Request intro →Lilly Asia Ventures
8 Life Sciences deals in the last 24 months · 5 at a nearby stage · 7 in East China
Request intro →HongShan
7 Life Sciences deals in the last 24 months · 3 at a nearby stage · 6 in East China
Request intro →Matrix Partners China
6 Life Sciences deals in the last 24 months · 4 at a nearby stage · 4 in East China
Request intro →Ranked by each firm’s deals in this sector over the last 24 months, weighted by nearby stage and shared geography. Indicative only — no rating judgment.